These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7099169)

  • 1. Complement-mediated fragmentation of soluble and insoluble immune complexes containing porcine anti-DNP antibodies.
    Miklós K; Kulics J; Franĕk F; Füst G; Gergely J
    Mol Immunol; 1982 Feb; 19(2):307-12. PubMed ID: 7099169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of immunoglobulin isotype and antibody affinity on complement-mediated inhibition of immune precipitation and solubilization.
    Johnson A; Harkin S; Steward MW; Whaley K
    Mol Immunol; 1987 Nov; 24(11):1211-7. PubMed ID: 3696168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between precipitating and nonprecipitating antibodies in the formation of immune complexes.
    Cosio FG; Birmingham DJ; Sexton DJ; Hebert LA
    J Immunol; 1987 Apr; 138(8):2587-92. PubMed ID: 3559208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement-mediated solubilization of immune precipitates prepared with antibodies of different avidity.
    Stassen FL; Beek CJ
    J Immunol; 1979 Aug; 123(2):535-42. PubMed ID: 313415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement-mediated solubilization of rat IgA immune precipitates.
    Rits M; Hiemstra PS; van Es LA; Bazin M; Vaerman JP; Daha MR
    Mol Immunol; 1987 Oct; 24(10):1047-53. PubMed ID: 3683402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of antibody isotype on the activation of C3 and C4 by immune complexes formed in the presence of serum: correlation with the prevention of immune precipitation.
    Stewart WW; Johnson A; Steward MW; Whaley K; Kerr MA
    Mol Immunol; 1990 May; 27(5):423-8. PubMed ID: 2366759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissociation of primary antigen-antibody bonds is essential for complement mediated solubilization of immune precipitates.
    Johnston A; Auda GR; Kerr MA; Steward MW; Whaley K
    Mol Immunol; 1992 May; 29(5):659-65. PubMed ID: 1584232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunologic defense mechanism in the solubilization of immune complexes by complement].
    Tomooka K; Yasuda M; Nobunaga M; Sakai K
    Nihon Rinsho; 1988 Sep; 46(9):1968-73. PubMed ID: 3241388
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibody activity and complement-mediated solubilization of precipitates during the immune response.
    Stassen FL; Beek CJ
    Immunology; 1982 Jun; 46(2):289-95. PubMed ID: 7084992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoglobulin-mediated shifting of immune complexes to increased complement-dependent solubility and immunoadherence.
    Spycher MO; Späth PJ; Häsig A; Nydegger UE
    Mol Immunol; 1984 Jun; 21(6):497-505. PubMed ID: 6431266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The activation of C3 and C4 in human serum by immune complexes containing mouse monoclonal antibodies of different isotype and affinity: effects on solubilisation.
    Stewart WW; Johnson A; Steward MW; Whaley K; Kerr MA
    Mol Immunol; 1988 Dec; 25(12):1355-61. PubMed ID: 3266294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of polymeric IgA in complement-mediated solubilization of IgG and IgA immune complexes.
    Schena FP; Pastore A; Montinaro V
    Am J Kidney Dis; 1988 Nov; 12(5):433-6. PubMed ID: 3055971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement-mediated delay in immune complex clearance from the blood owing to reduced deposition outside the reticuloendothelial system.
    Skogh T; Stendahl O
    Immunology; 1983 May; 49(1):53-9. PubMed ID: 6404812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced complement-mediated immune complex solubilizing capacity and the presence of incompletely solubilized immune complexes in SLE sera.
    Baatrup G; Petersen I; Jensenius JC; Svehag SE
    Clin Exp Immunol; 1983 Nov; 54(2):439-47. PubMed ID: 6652967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of rat complement by soluble and insoluble rat IgA immune complexes.
    Rits M; Hiemstra PS; Bazin H; Van Es LA; Vaerman JP; Daha MR
    Eur J Immunol; 1988 Dec; 18(12):1873-80. PubMed ID: 3220102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The subclass heterogeneity of pig IgG.
    Franek F
    Vet Immunol Immunopathol; 1987 Dec; 17(1-4):79-89. PubMed ID: 3433672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of asymmetric non-precipitating antibody: presence of a carbohydrate residue in only one Fab region of the molecule.
    Labeta MO; Margni RA; Leoni J; Binaghi RA
    Immunology; 1986 Feb; 57(2):311-7. PubMed ID: 3081439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solubilization of IgA immune precipitates by complement.
    Miller GW
    J Immunol; 1976 Oct; 117(4):1374-7. PubMed ID: 977953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular composition of complement-solubilized complexes and their fate in vivo.
    Malasit P; Bartolotti SR; Humphrey JH
    Immunology; 1983 Apr; 48(4):779-89. PubMed ID: 6832806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of precipitating and nonprecipitating antibodies in glomerular immune complex formation.
    Cosio FG; Bakaletz AP; Mahan JD
    Kidney Int; 1990 Jun; 37(6):1429-37. PubMed ID: 2194065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.